Search for: "United States v. Bayer Company"
Results 121 - 131
of 131
Sorted by Relevance
|
Sort by Date
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles) Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise mechanisms for… [read post]
27 Jun 2008, 10:04 am
Porsche AG: (Class 46), WIPO: Yell Limited v Yell.travel: domain name yell.travel to be transferred to Yell Limited: (Class 46), Some see rise in non-traditional trade marks; national registries not yet: (Intellectual Property Watch) Global - Patents Lower patentability standards – strategic responses: (IP Thinktank), IP Business Congress sees Finnish inventor become a millionaire: (IAM), Ron Slusky: Five prescriptions for effectively analysing an invention and then… [read post]
9 Oct 2011, 3:30 pm
All state laws vary. [read post]
22 Oct 2009, 2:59 pm
" People tend to forget that Bayer AG first invented aspirin in 1897 but lost its rights to the brand name in the United States by allowing it to escape into the public domain, i.e., go generic or commit "genericide," a tragic commercial fate shared famously by Duncan Yo-Yo Co. [read post]
3 Jan 2022, 12:39 pm
(Please note that these figures reflect only federal court securities class action lawsuit filings; the filing numbers do not include state court securities class action lawsuit filings during the year.) [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still… [read post]
9 Aug 2010, 10:14 pm
The two companies formed a strategic partnership, enabled their two programs to work together, and collaborated to sell the two programs as a unit. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
9 Sep 2020, 6:18 am
Introduction In 1998, Bill Clinton signed the Digital Millennium Copyright Act (DMCA), a sweeping overhaul of U.S. copyright law notionally designed to update the system for the digital era. [read post]
16 Sep 2016, 8:30 am
MacPherson v. [read post]
15 Mar 2007, 2:12 am
The complainants were Swiss company F. [read post]
